Attribution & Authorship Policy
A cornerstone of any scientific investigation is attribution. OSDD ensures that all contributions made on OSDD are attributed to the concerned. Intellectual Property, in addition to its other roles, plays a role in attribution (of authorship, invention, etc). Therefore in an open source scientific environment of drug discovery for tropical diseases IP could have a limited role to ensure attribution. Therefore if individual researchers would like to patent their inventions for this purpose, they are welcome to do so, but will need to provide worldwide royalty free non exclusive license to OSDD to work further. OSDD will take forward such molecules in the drug discovery pipeline and make it available without IP encumbrances. Thus IP may play a limited role but within the premises of affordability and accessibility.
A micro-attribution system will be followed for all contributions. Based on the peer-review contributors would get rewards in form of credit points. Each activity or a defined problem will have a per-determined set of points or rewards associated to it. All probable prospective activity would be given prior points in terms of weightage, for example, lead optimization would have higher weightage than protein expression. The points can be accrued over time for all the contributions to the project.
Since the inception of OSDD in September 2008, a large number of activities have been initiated with several results being produced and some of these have been already published. OSDD encourages the Principal Investigators (PI) to publish their results in peer reviewed publications. OSDD Consortium, in keeping with the spirit of collaboration, has further reiterated the following policy for authorship of various papers for further clarification. All projects of OSDD are required to follow this authorship policy.